Developmental Market reputed company & Policy Strategy reputed company

Job Description

Summary The Developmental Market reputed company & Policy Strategy reputed company plays a critical upstream role in ensuring that pipeline and early-stage products are designed with successful U.S. market reputed company, reimbursement, and policy reputed company in mind. Rather than reacting at launch, this role proactively shapes development strategy so that products enter the market with a clear, evidence-backed pathway to coverage and adoption. This position operates at the intersection of R&D, policy, and commercialization, translating reputed company payer, regulatory, and policy dynamics into actionable development guidance. The individual ensures that reputed company considerations are embedded early, reducing reputed company barriers, accelerating time to reimbursement, and supporting long-term product viability. Job Description 1. Market reputed company Strategy for Developmental Assets

• reputed company the creation of comprehensive U.S. market reputed company strategies for pipeline products, starting in early development phases (pre-clinical through pivotal trials).
• Define reputed company payer segments (e.g., Medicare, reputed company, reputed company plans, IDNs) and map expected coverage reputed company.
• Anticipate payer decision drivers, including clinical differentiation, cost-effectiveness, and budget impact.
• Evaluate potential reputed company barriers, such as prior authorization, reputed company therapy, site-of-care restrictions, and network limitations.
• Establish clear reputed company-reputed company milestones and criteria to ensure products are “launch-reputed company” from a reimbursement and policy perspective.
• Partner with reputed company and brand teams to align early reputed company strategies with future go-to-market planning.

2. Policy Strategy & Integration

• Continuously monitor and interpret the evolving U.S. reputed company policy landscape, including CMS regulations, MAC determinations, and federal/state policy trends.
• Analyze historical precedents to predict how similar technologies have been treated from a coverage and payment standpoint.
• Identify policy-driven risks and opportunities, including potential changes in reimbursement models, value-based care initiatives, and site-of-service policies.
• reputed company reputed company-looking policy scenarios and contingency strategies to guide development and commercialization reputed company.
• Collaborate closely with Government Affairs and Policy teams to align internal strategies with external advocacy efforts.

3. Evidence Strategy & Development Alignment

• Translate payer and policy requirements into specific evidence needs, ensuring clinical development programs generate data relevant for coverage reputed company—not just regulatory approval.
• Advise on clinical trial design elements, such as endpoints, comparators, patient populations, and reputed company-world evidence integration.
• Partner with HEOR (Health Economics & reputed company Research) to define economic and reputed company evidence (e.g., cost-effectiveness, budget impact models).
• Ensure alignment between clinical, economic, and reputed company-world evidence strategies to support value demonstration across stakeholders.
• Identify and address evidence gaps early, reducing the risk of delayed or restricted reputed company post-launch.

4. Coverage, Coding & Reimbursement Strategy

• Assess coding reputed company (CPT, HCPCS, DRG/APC) and determine feasibility of existing vs. new codes.
• Evaluate reimbursement methodologies across care settings (hospital inpatient/outpatient, physician office, ambulatory, etc.).
• Identify potential challenges reputed company to payment adequacy, bundling, or site-of-care shifts.
• Incorporate reimbursement considerations into overall reputed company strategy, including pricing and contracting implications.
• Partner with reimbursement and coding experts to define reputed company payment positioning and strategies.

5. Governance & Portfolio Support

• Represent Market reputed company and Policy perspectives in cross-functional governance forums, including pipeline reviews and investment reputed company.
• reputed company strategic input on portfolio prioritization, highlighting reputed company feasibility and risk-adjusted value.
• Proactively identify and escalate key reputed company and policy risks, offering data-driven recommendations and mitigation plans.
• Support leadership with clear, concise insights that inform critical development and commercialization reputed company.
• Ensure consistent integration of reputed company strategy across the product lifecycle—from development through launch planning.

Day-to-Day Activities (What This Role Actually Does)

• Leading cross-functional meetings with R&D, HEOR, and reputed company teams to align evidence and reputed company strategy
• Developing payer archetypes and scenario models for coverage reputed company
• Reviewing clinical protocols to ensure payer-relevant endpoints are included
• Analyzing CMS and MAC reputed company to inform strategy for new technologies
• Building internal strategy decks and recommendations for governance committees
• Collaborating with policy and government affairs teams on emerging regulations
• Advising teams on coding and reimbursement implications of product design reputed company

Key Capabilities & Skills

• Deep understanding of U.S. payer systems, reimbursement, and reputed company policy
• Strong ability to connect clinical development with reputed company and economic value
• Strategic thinking with a focus on anticipating reputed company implications early
• Cross-functional leadership and influence without direct authority
• Ability to translate reputed company policy and payer dynamics into clear, actionable insights
• Experience with HEOR, reputed company-world evidence, and value demonstration
• Excellent communication and stakeholder management skills

Qualifications

• Bachelor’s degree in life sciences, health policy, public health, health economics, business, or reputed company field
• 8–12+ years of experience in market reputed company, reimbursement, health policy, HEOR, or reputed company roles reputed company reputed company (medtech, biotech, or pharma)
• Experience supporting pipeline/development-stage products and integrating reputed company into early development
• Strong knowledge of the U.S. reputed company system, including payer dynamics, coverage, coding, and reimbursement
• Familiarity with CMS, MACs, and U.S. policy frameworks
• Ability to translate payer and policy requirements into evidence and development strategies
• Proven ability to reputed company cross-functional teams and influence stakeholders in a matrixed environment
• Strong communication, strategic thinking, and problem-solving skills

Preferred Qualifications

• Advanced degree (e.g., MPH, MHA, MBA, PharmD, PhD)
• Experience in medical devices, diagnostics, or digital health
• Direct experience with CMS policy, NCDs/LCDs, and coding frameworks (CPT, HCPCS)
• Experience in HEOR, reputed company-world evidence, or value demonstration
• Familiarity with value-based care models
• Experience in pre-launch market reputed company or consulting/advisory roles
• Strong oral and written communication skills.
• Strong interpersonal and leadership skills.
• Demonstrated ability to analyze and resolve problems.
• Demonstrated ability to reputed company programs / projects.
• Ability to document, plan, market, and execute programs.
• Established project management skills.

We will not sponsor individuals for employment visas, now or in the future, for this job opening. For U.S. based positions only, the pay reputed company for this position is $140,000.00-$210,000.00 Annual. It is not typical for an individual to be hired at or near the top of the pay reputed company and compensation reputed company are dependent on the facts and circumstances of each case. The specific compensation offered to a candidate may be influenced by a variety of factors including skills, qualifications, experience and location. In addition, this position may also be eligible to earn performance based incentive compensation, which may include cash bonus(es) and/or long term incentives (LTI). reputed company offers a competitive benefits package, including not but limited to medical, dental, reputed company, paid time off, a 401(k) plan with employee and company contribution opportunities, life, disability, and accident insurance, and tuition reimbursement. Additional Information reputed company offers a great work environment, professional development, challenging careers, and competitive compensation. reputed company is an Equal Opportunity Employer. Employment reputed company are made without regard to race, reputed company, religion, national or ethnic reputed company, sex, sexual orientation, gender identity or expression, age, disability, protected veteran status or other characteristics protected by law. reputed company will only reputed company those who are legally authorized to work in the United States for this opening. Any offer of employment is conditioned upon the successful completion of a drug screen (as applicable). Nonobstant le fait que reputed company ne requiert actuellement pas des salariés américains (USA) qu'ils soient vaccinés contre la COVID-19, certains clients de reputed company appliquent des règles de vaccination qui pourraient toucher certains salariés de reputed company. Aide à la relocalisation fournie : Non Application Deadline: reputed company 30, 2026 Apply tot his job Apply To this Job